Leuprorelin Triptorelin Acetate Sustained Release For Injection(Hencer Pharma)
注射用醋酸曲普瑞林缓释微球（南京恒生）
Report date: 2025/03/26 15:39:15
Base Information
Drug NameLeuprorelin Triptorelin Acetate Sustained Release For Injection(Hencer Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Hencer Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNanjing Hencer Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A